Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Research at Massachusetts General Hospital includes multitude of hospital-wide centers, institutes and programs as well as collaborations with other institutions.
Bench-to-bedside research led from preclinical experiments to a durable response among patients with a difficult-to-treat form of colorectal cancer.
In U.S. patients who underwent major cancer operations, the incidence of suicide was significantly higher than the general population.
Nonablative fractional lasers, which deliver heat to the skin in a fractional manner that leaves it fully intact after treatment, cut the risk of basal cell and squamous cell carcinomas by about half.
The oral drug is currently being evaluated in phase I clinical trials for Parkinson’s disease.
Specific neutralizing antibodies are key to sustained tolerance.
Using a multivariate artificial intelligence (AI) model initially developed to predict the risk of high-flow oxygen therapy or mechanical ventilation requirement during the COVID-19 pandemic.
